🦊/Lists

Biotech Investors & VC Firms in United States

1280 firms in this list, with a median first check of $500K. 281 of them lead rounds. Generated from verified public data and updated continuously.

Esplanade Ventures
TorontoPre-Seed–Series B
11 people
Angelini Ventures
RomeSeed–Growth
4 people
Criteria Bio Ventures
BarcelonaSeed–Late Stage
7 people
Elysia Capital
Turin
6 people
Impact India Investment Partners
MumbaiSeed
12 people
CPT Capital
LondonPre-Seed–Late Stage
8 people
InHealth Ventures
LondonPre-Seed–Series A$500K – $3M
5 people
Diffusion Capital Partners
IstanbulPre-Seed–Series A$439K – $2.7M
10 people
CP Ventures
North SydneyPre-Seed–Series A$100K – $500K
3 people
Smilegate Investment
SeoulSeed–Growth$694K – $35M
11 people
Ventac Partners
Gentofte
11 people
2080 Ventures
Pre-Seed–Growth$100K – $500K
1 person
Novalis Biotech
GhentPre-Seed–Series A
7 people
PM Equity Partner
LausanneSeries A–Growth$2M – $50M
10 people
SEEDS Capital
SingaporePre-Seed–Series B$250K – $9M
Deep Checks
Pre-Seed–Seed$100K – $500K
6 people
Sectoral Asset Management
MontrealSeries A–Late Stage
9 people
SBI Investment
TokyoPre-Seed–Growth$2M – $227M
1 person
Green Generation Fund
BerlinPre-Seed–Series A$540K – $2.7M
Matrix Partners China
BeijingSeed–Late Stage$1.6M – $113M
6 people
Oriza Seed Capital (Oriza Yuandian)
SuzhouPre-Seed–Series A$213K – $60M
9 people
Mitsubishi UFJ Capital
TokyoPre-Seed–Late Stage$952K – $269M
5 people
Fresenius Medical Care Ventures
Bad HomburgSeed–Late Stage
7 people
Waarde Capital
CapellenPre-Seed–Late Stage$15M
5 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.